Knockdown of Inwardly Rectifying Potassium Channel Kir2.2 Suppresses Tumorigenesis by Inducing Reactive Oxygen Species–Mediated Cellular Senescence

Molecular Cancer Therapeutics - Tập 9 Số 11 - Trang 2951-2959 - 2010
In‐Kyoung Lee1, Chaehwa Park1, Won Ki Kang1
1Authors' Affiliations: 1Biomedical Research Institute, Samsung Medical Center; 2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Tóm tắt

Abstract Senescence is an important determinant of treatment outcome in cancer therapy. In the present study, we show that knockdown of the inwardly rectifying K+ channel Kir2.2 induced growth arrest without additional cellular stress in cancer cells lacking functional p53, p16, and/or Rb. Kir2.2 knockdown also induced senescence-associated β-galactosidase activity and upregulated senescence marker proteins in multiple cancer cell lines derived from different tissues, including prostate, stomach, and breast. Interestingly, knockdown of Kir2.2 induced a significant increase in reactive oxygen species (ROS) that was accompanied by cell cycle arrest, characterized by significant upregulation of p27, with concomitant downregulation of cyclinA, cdc2, and E2F1. Kir2.2 knockdown cells displayed increased levels of PML bodies, DNA damage (γH2AX) foci, senescence-associated heterochromatin foci, mitochondrial dysfunction, secretory phenotype, and phosphatase inactivation. Conversely, overexpression of Kir2.2 decreased doxorubicin-induced ROS accumulation and cell growth inhibition. Kir2.2 knockdown-induced cellular senescence was blocked by N-acetylcysteine, indicating that ROS is a critical mediator of this pathway. In vivo tumorigenesis analyses revealed that tumors derived from Kir2.2 knockdown cells were significantly smaller than those derived from control cells (P < 0.0001) and showed a remarkable increase in senescence-associated proteins, including senescence-associated β-galactosidase, p27, and plasminogen activator inhibitor-1. Moreover, the preestablished tumors are reduced in size after the injection of siKir2.2 (P = 0.0095). Therefore, we propose for the first time that Kir2.2 knockdown induces senescence of cancer cells by a mechanism involving ROS accumulation that requires p27, but not Rb, p53, or p16. Mol Cancer Ther; 9(11); 2951–9. ©2010 AACR.

Từ khóa


Tài liệu tham khảo

Schmitt, 2002, A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy, Cell, 109, 335, 10.1016/S0092-8674(02)00734-1

Roninson, 2003, Tumor cell senescence in cancer treatment, Cancer Res, 63, 2705

te Poele, 2002, DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res, 62, 1876

Chang, 1999, Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, Oncogene, 18, 4808, 10.1038/sj.onc.1203078

Hara, 1996, Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence, Mol Cell Biol, 16, 859, 10.1128/MCB.16.3.859

Alexander, 2001, Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence, Mol Cell Biol, 21, 3616, 10.1128/MCB.21.11.3616-3631.2001

Park, 2006, E2F-1 is a critical modulator of cellular senescence in human cancer, Int J Mol Med, 17, 715

Park, 2006, Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis, Mol Cancer Ther, 5, 3191, 10.1158/1535-7163.MCT-06-0570

Lee, 2010, A novel senescence-evasion mechanism involving Grap2 and cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment, Cancer Res, 70, 1, 10.1158/0008-5472.CAN-09-3791

Wang, 1992, K+-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes, J Cell Physiol, 152, 185, 10.1002/jcp.1041520123

Ouadid-Ahidouch, 2004, Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells, Biochem Biophys Res Commun, 316, 224, 10.1016/j.bbrc.2004.02.041

Ouadid-Ahidouch, 2000, KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation, Biochem Biophys Res Commun, 278, 272, 10.1006/bbrc.2000.3790

Yao, 1999, Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer, Life Sci, 65, 55, 10.1016/S0024-3205(99)00218-0

Skryma, 1997, Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation, Prostate, 33, 112, 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M

Ferbeyre, 2000, PML is induced by oncogenic ras and promotes premature senescence, Genes Dev, 14, 2015, 10.1101/gad.14.16.2015

Zhou, 2006, DNA damage evaluated by γH2AX foci formation by a selective group of chemical/physical stressors, Mutat Res, 604, 8, 10.1016/j.mrgentox.2005.12.004

Narita, 2003, Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence, Cell, 113, 703, 10.1016/S0092-8674(03)00401-X

Kuilman, 2009, Senescence-messaging secretome: SMS-ing cellular stress, Nat Rev Cancer, 9, 81, 10.1038/nrc2560

Kim, 2003, Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence, J Biol Chem, 278, 37497, 10.1074/jbc.M211739200

Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc Natl Acad Sci U S A, 92, 9363, 10.1073/pnas.92.20.9363

Moiseeva, 2009, Mitochondrial dysfunction contributes to oncogene-induced senescence, Mol Cell Biol, 29, 4495, 10.1128/MCB.01868-08

Chen, 1995, Oxidative DNA damage and senescence of human diploid fibroblast cells, Proc Natl Acad Sci U S A, 92, 4337, 10.1073/pnas.92.10.4337

Royall, 1993, Evoluation of 2′,7 ′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells, Arch Biochem Biophys, 302, 348, 10.1006/abbi.1993.1222

Muller, 1998, Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity, Int J Mol Med, 1, 491

Tsang, 2003, Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis, Life Sci, 73, 2047, 10.1016/S0024-3205(03)00566-6

Macip, 2002, Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence, EMBO J, 21, 2180, 10.1093/emboj/21.9.2180

Staal, 1990, Intracellular thiols regulate activation of nuclear factor κ B and transcription of human immunodeficiency virus, Proc Natl Acad Sci U S A, 87, 9943, 10.1073/pnas.87.24.9943

Ames, 1993, Oxidants, antioxidants, and the degenerative diseases of aging, Proc Natl Acad Sci U S A, 90, 7915, 10.1073/pnas.90.17.7915

Beckman, 1998, The free radical theory of aging matures, Physiol Rev, 78, 547, 10.1152/physrev.1998.78.2.547

Finkel, 2000, Oxidants, oxidative stress and the biology of ageing, Nature, 408, 239, 10.1038/35041687

Rane, 1999, Ion channels as physiological effectors for growth factor receptor and Ras/ERK signaling pathways, Adv Second Messenger Phosphoprotein Res, 33, 107, 10.1016/S1040-7952(99)80007-X

Chittajallu, 2002, Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1-S phase progression of the cell cycle, Proc Natl Acad Sci U S A, 99, 2350, 10.1073/pnas.042698399

Collado, 2000, Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1, J Biol Chem, 275, 21960, 10.1074/jbc.M000759200